Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications

International Journal of Biological Macromolecules

Volumn 66, Issue , 2014, Pages 144-150

  Agudelo, Daniel ^a   Bourassa, Philippe ^a   Bérubé, Gervais ^a   Tajmir Riahi, Heidar Ali ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Conformation; DNA; Doxorubicin; Intercalation; Molecular modeling

Indexed keywords

DOUBLE STRANDED DNA; DOXORUBICIN; N TRIFLUOROACETYLDOXORUBICIN; ANTINEOPLASTIC AGENT; DNA; DNA ADDUCT; DOXORUBICIN-DNA; INTERCALATING AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA STRUCTURE; DRUG DETERMINATION; DRUG DNA INTERACTION; DRUG EFFECT; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; GENE DUPLICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; MOLECULAR DOCKING; MOLECULAR DYNAMICS; CARCINOMA; CHEMISTRY; COLONIC NEOPLASMS; CONFORMATION; DNA ADDUCT; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA; DNA ADDUCTS; DOXORUBICIN; HUMANS; INTERCALATING AGENTS; NUCLEIC ACID CONFORMATION;

EID: 84900371949     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.02.028     Document Type: Article

References (43)

1. Ma P., Mumper R.J. Nano Today 2013, 8:313-331.
2. Carvalho C., Santos R.X., Cardoso S., Correia S., Oliveira P.J., Santos M.S., Moreia P.I. Curr. Med. Chem. 2009, 16:3267-3285.
3. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Pharmacol. Rev. 2004, 56:185-229.
4. A. Turner, L.C. Li, T. Pilli, L. Qian, E.L. Wiley, S. Setty, K. Christov, L. Ganesh, A.V. Maker, P. Li, P. Kanteti, T.K. D. Gupta, B.S. Prabhakar, PLOS ONE 8 (2013) 1-8, e56817.
5. Goto S., Ihara Y., Urata Y., Izumi S., Abe K., Koji T., Kondo T. FASEB J. 2001, 15:2702-2713.
6. Jurisicova A., Lee H.-J., D'Estaing S.G., Tilly J., Perez G.I. Cell Death Different. 2006, 13:1466-1474.
7. Sinha B.K., Mimnaugh E.G. Free Radic. Biol. Med. 1990, 8:567-581.
8. Acton E.M., Tong G.L. J. Med. Chem. 1981, 24:669-673.
9. Bérubé G., Richardson V.J., Ford C.H.J. Synth. Commun. 1991, 21:931-944.
10. Marmur J. J. Mol. Biol. 1961, 3:208-218.
11. Vijayalakshmi R., Kanthimathi M., Subramanian V. Biochem. Biophys. Res. Commun. 2000, 271:731-734.
12. Reichmann M.E., Rice S.A., Thomas C.A., Doty P. J. Am. Chem. Soc. 1954, 76:3047-3053.
13. Alex S., Dupuis P. Inorg. Chim. Acta 1989, 157:271-281.
14. Beng X.D.B., Zhilian Y., Eccleston M.E., Swartling J., Slater N.K.H., Kaminski C.F. Nanomed. Nanotech. Biol. Med. 2008, 4:49-56.
15. Dufour C., Dangles O. Biochim. Biophys. Acta 2005, 1721:164-173.
16. Froehlich E., Jennings C.J., Sedaghat-Herati M.R., Tajmir-Riahi H.A. J. Phys. Chem. B 2009, 113:6986-6993.
17. He W., Li Y., Xue C., Hu Z., Chen X., Sheng F. Bioorg. Med. Chem. 2005, 13:1837-1845.
18. Sarzehi S., Chamani J. Intl. J. Biol. Macromol. 2010, 47:558-569.
19. Bi S., Ding L., Tian Y., Song D., Zhou X., Liu X., Zhang H. J. Mol. Struct. 2004, 703:37-45.
20. Iranfar H., Rajabi O., Salari R., Chamani J. J. Phys. Chem. B 2012, 116:1951-1964.
21. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer, New York. third ed.
22. Tayeh N., Rungassamy T., Albani J.R. J. Pharm. Biomed. Anal. 2009, 50:107-116.
23. Privé G.G., Yanagi K., Dickerson R.E. J. Mol. Biol. 1991, 217:177-199.
24. Ahmed Ouameur A., Tajmir-Riahi H.A. J. Biol. Chem. 2004, 279:42041-42054.
25. Andrushchenko V.V., Leonenko Z., van de Sande H., Wieser H. Biopolymers 2000, 61:243-260.
26. Dovbeshko G.I., Chegel V.I., Gridina N.Y., Shishov O.P., Tryndiak Y.M., Todor V.P., Solyanik G.I. Biospectroscopy 2000, 67:470-486.
27. H. Arakawa, R. Ahmad, M. Naoui, H.A. Tajmir-Riahi, J. Biol. Chem. 275 (2000) 10150-10153.
28. Sh.Nafisi A.A., Saboury N., Keramat J.F., Neault H.A., Tajmir-Riahi J. Mol. Struct. 2007, 827:35-43.
29. Vorlickova M. Biophys. J. 1995, 69:2033-2043.
30. Kypr J., Vorlickova M. Biopolymers (Biospectroscopy) 2002, 67:275-277.
31. Kankia B.I., Bukin V., Bloomfiled V.A. Nucl. Acids Res. 2001, 29:2795-2801.
32. Mandeville J.S., Tajmir- Riahi H.A. Biomacromolecules 2010, 11:465-472.
33. Charbonneau D.M., Tajmir-Riahi H.A. J. Phys. Chem. B 2010, 114:1148-1155.
34. Bourassa P., Kanakis D.C., Tarantilis P., Polissiou M.G., Tajmir-Riahi H.A. J. Phys. Chem. 2010, B114:3348-3354.
35. Mandeville J.S., N'soukpoé-Kossi C.N., Neault J.F., Tajmir-Riahi H.A. Biochem. Cell Biol. 2010, 88:469-477.
36. Jiang M., Xie M.X., Zheng D., Liu Y., Li X.Y., Chen X. J. Mol. Struct. 2004, 692:71-80.
37. Zhang G., Que Q., Pan J., Guo J. J. Mol. Struct. 2008, 881:132-138.
38. Zhuang X., Ha T., Kim H.D., Centner T., Labeit S., Steven Chu S. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:14241-14244.
39. Lau A., Bérubé G., Ford C.H.J. Bioorg. Med. Chem. 1995, 3:1299-1304.
40. Lau A., Bérubé G., Ford C.H.J., Gallant M. Bioorg. Med. Chem. 1995, 3:1305-1312.
41. Menna P., Paz O.G., Chello M., Covino E., Salvatorelli E., Minotti G. Expert Opin. Drug Saf. Suppl. 2012, 1:S21-S36.
42. Box V.G.S. J. Mol. Graphs Model. 2007, 26:14-19.
43. Weiss R.B. Sem. Oncol. 1992, 19:670-686.